Josh Denny

A computational method that uses hospital billing codes and electronic health records can identify genetic disease cases before clinical teams do. Read More

Scarcely a year after its national launch, the “All of Us” research program, which aims to accelerate the prevention and treatment of disease, has enrolled more than 230,000 research participants — more than a fifth of its recruitment goal of 1 million people. All Read More

A national study is seeking to determine whether genetic testing can help physicians choose the best drugs for their patients to relieve pain and depression. Read More

On Sunday, May 6, Vanderbilt University Medical Center (VUMC) participated in the national launch of the National Institutes of Health’s All of Us Research Program, a momentous effort to advance individualized prevention, treatment and care for people of all backgrounds. In July 2016, VUMC… Read More

Officials with Vanderbilt University Medical Center announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development. Read More

Patients diagnosed with heart failure, stroke, infertility and kidney failure could actually be suffering from rare and undiagnosed genetic diseases. Read More

Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center. Read More

Consuelo Wilkins, M.D., MSCI, and Joshua Denny, M.D., M.S., discussed the potential of precision medicine during their recent Flexner Discovery Lecture. Read More

A computer-based method pioneered at Vanderbilt is being used to compare subtypes of rheumatoid arthritis. Read More

Vanderbilt University Medical Center (VUMC) has been chosen by the National Institutes of Health (NIH) to be the Data and Research Support Center for the Precision Medicine Initiative Cohort Program, a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people, federal officials have announced. Read More

Federal officials with the White House and National Institutes of Health (NIH) announced today that Vanderbilt University Medical Center (VUMC) will lead the Direct Volunteers Pilot Studies under the first grant to be awarded in the federal Precision Medicine Initiative Cohort Program. Read More

Vanderbilt’s Joshua Denny, M.D., M.S., associate professor of Biomedical Informatics and Medicine and a recognized leader in the national Precision Medicine Initiative, delivered last week’s Flexner Discovery Lecture. Read More

Vanderbilt University researchers have received two major federal grants — totaling $7.6 million over four years — to support groundbreaking research aimed at making genetic information a routine part of patients’ electronic medical records. Read More

Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given. Read More

Affirmation of Vanderbilt University Medical Center’s high profile in precision medicine came last week when a new working group convened by the National Institutes of Health (NIH) visited Vanderbilt for a two-day public workshop devoted to planning a key component of the federal Precision Medicine Initiative announced earlier this year by President Obama. Read More

On May 28-29 at Vanderbilt, the Precision Medicine Initiative Working Group of the Advisory Committee to the Director of the National Institutes of Health (NIH) will hold a public workshop devoted to research cohorts and electronic health records. Read More

Josh Denny, M.D., M.S., associate professor of Biomedical Informatics and Medicine, will help guide planning for the precision medicine initiative announced by President Obama in his January State of the Union Address. Read More

The Precision Medicine Initiative is a national effort announced by President Obama during his State of the Union address to provide more effective treatment and prevention strategies for individuals by taking into account their unique genetic, environmental and lifestyle factors. Read More

Biomedical informatics is a science that draws connections between data and medicine, whether those data concern diseases, health care processes or human biology in the form of genomics and proteomics. Everyone who studies health records has the same goal: more precise medicine, leading to improved patient outcomes. Read More

Faculty members Josh Denny, M.D., M.S., associate professor of Biomedical Informatics and Medicine, and Paul Harris, Ph.D., associate professor of Biomedical Informatics and research associate professor of Biomedical Engineering, are among six fellows elected this year to the American College of Medical Informatics. Read More